Join to View Full Profile
3838 North Campbell AveTucson, AZ 85719
Phone+1 520-694-8888
Dr. Arshad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Junaid Arshad, based in Tucson, AZ, is a specialist in Internal Medicine with subspecialties in Hematology and Oncology. He completed his residency in Internal Medicine at St Mary's Hospital (Waterbury) from 2014 to 2017 and pursued a fellowship in Hematology and Medical Oncology at the University of Miami/Jackson Health System from 2017 to 2020. He graduated in 2010 with an M.B;B.S and received the Col. Elahi Baksh Medal for Outstanding Performance from King Edward Medical University. Dr. Arshad has several publications, including studies on bisphosphonates, gastrointestinal cancer therapies, and neuroendocrine tumors, with some appearing in journals like Cureus, International Journal of Molecular Sciences, Seminars in Interventional Radiology, and Journal of Clinical Oncology.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2017 - 2020
St Mary's Hospital (Waterbury)Residency, Internal Medicine, 2014 - 2017
King Edward Medical UniversityClass of 2010, M.B;B.S, Col. Elahi Baksh Medal for Outstanding Performance
Certifications & Licensure
CA State Medical License 2017 - 2026
AZ State Medical License 2021 - 2025
WA State Medical License 2019 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Efficacy of Bisphosphonates in Reducing Fracture Risk Among Postmenopausal Women With Osteoporosis.Mutea Ullah, Junaid Arshad, Uzma Anwar, Shehriyar Khan, Anum Amjad
Cureus. 2024-11-01 - Concurrent Stage III Unresectable Duodenal Adenocarcinoma and Metastatic Gastrointestinal Stromal Tumor Treated With Combination of Imatinib and mFOLFIRI.Amith Rao, Rohit Rao, Megan K Taylor, Mohammad Khreiss, Junaid Arshad
Cureus. 2024-04-01 - 1 citationsMyeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers.Junaid Arshad, Amith Rao, Matthew L Repp, Rohit Rao, Clinton Wu
International Journal of Molecular Sciences. 2024-03-04
Lectures
- Identification of genomic alterations by circulating tumor DNA in leiomyosarcoma: A molecular analysis of 73 patients.2019 ASCO Annual Meeting - 6/1/2019
- Utility of circulating tumor DNA (ctDNA) in the management of patients with gastrointestinal stromal tumor (GIST): Analysis of 152 patients.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
Colorectal Cancer Awareness Month: Local Doctors Urge Screenings to Save LivesMarch 3rd, 2023- A First Look at Contact Tracing Apps Muhammad Ajmal Azad, Junaid Arshad, Ali Akmal, Sidrah Abdullah, Farhan Ahmad, Muhammad Imran, FarhanApril 19th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
